Create a free research account to view current pricing and place an order.
How does Thy Alpha 1 work in research models?
Thymosin Alpha-1 is an immune-modulating thymic peptide researched for T-cell signaling, dendritic-cell activity, innate/adaptive immune coordination, and host-defense pathway support.
What is the half-life of Thy Alpha 1?
Half-life: Short-to-moderate; clinical context dependent.
Human clinical formulations have immune-modulatory dosing schedules; research preparations vary. Functional immune signaling may persist beyond plasma exposure.
Research dosing reference
0.3-1.6 mg daily or several times weekly depending on immune protocol objective.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 0.3 mg | 6 units |
| 1.0 mg | 20 units |
| 1.6 mg | 32 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is Thy Alpha 1 reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Often administered several times weekly or daily in structured immune protocols.
Beginner escalation
Begin conservatively and monitor immune/inflammatory response.
Side-effect mitigation
Monitor injection irritation, flu-like feelings, fatigue, immune flares, or headache.
Stack compatibility
Pairs with immune-support frameworks; avoid combining with many immune-active peptides at initiation.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Common immune-support courses often use several-week blocks with marker/symptom reassessment before repeating or extending. Hormonal / Miscellaneous
Frequently asked questions
What is Thy Alpha 1 and how is it studied?
Thymosin Alpha-1 is an immune-modulating thymic peptide researched for T-cell signaling, dendritic-cell activity, innate/adaptive immune coordination, and host-defense pathway support. Thy Alpha 1 is catalogued in the Bioregulators / Organ Support group of this reference and is studied in laboratory and in-vitro models only.
What is known about the half-life of Thy Alpha 1?
Reference half-life for Thy Alpha 1: short-to-moderate; clinical context dependent. Functional immune signaling may persist beyond plasma exposure. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is Thy Alpha 1 stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is Thy Alpha 1 reconstituted for laboratory work?
The reference reconstitution for the 10 mg vial is 2 mL BAC Water, which gives a concentration of about 5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is Thy Alpha 1 FDA approved?
No. The research-grade Thy Alpha 1 described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration